DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies.
Saved in:
| Title: | DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies. |
|---|---|
| Authors: | Oostindie SC; Genmab, Utrecht, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., van der Horst HJ; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kil LP; Genmab, Utrecht, The Netherlands., Strumane K; Genmab, Utrecht, The Netherlands., Overdijk MB; Genmab, Utrecht, The Netherlands., van den Brink EN; Genmab, Utrecht, The Netherlands., van den Brakel JHN; Genmab, Utrecht, The Netherlands., Rademaker HJ; Genmab, Utrecht, The Netherlands., van Kessel B; Genmab, Utrecht, The Netherlands., van den Noort J; Genmab, Utrecht, The Netherlands., Chamuleau MED; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mutis T; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lindorfer MA; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA., Taylor RP; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA., Schuurman J; Genmab, Utrecht, The Netherlands., Parren PWHI; Genmab, Utrecht, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Lava Therapeutics, Utrecht, The Netherlands., Beurskens FJ; Genmab, Utrecht, The Netherlands., Breij ECW; Genmab, Utrecht, The Netherlands. ebj@genmab.com. |
| Source: | Blood cancer journal [Blood Cancer J] 2020 Apr 28; Vol. 10 (3), pp. 30. Date of Electronic Publication: 2020 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-020-0292-7 |
